BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 28710882)

  • 1. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome.
    Tchirikov M; Schlabritz-Loutsevitch N; Maher J; Buchmann J; Naberezhnev Y; Winarno AS; Seliger G
    J Perinat Med; 2018 Jul; 46(5):465-488. PubMed ID: 28710882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between maternal and neonatal outcome of PPROM in the cases of amniotic fluid index (AFI) of more and less than 5 cm.
    Mousavi AS; Hashemi N; Kashanian M; Sheikhansari N; Bordbar A; Parashi S
    J Obstet Gynaecol; 2018 Jul; 38(5):611-615. PubMed ID: 29426264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of ultrasound assessment in management of pregnancies with preterm prelabor rupture of membranes.
    Aviram A; Quaglietta P; Warshafsky C; Zaltz A; Weiner E; Melamed N; Ng E; Barrett J; Ronzoni S
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):806-814. PubMed ID: 31332850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preterm premature rupture of membranes: CNGOF Guidelines for clinical practice - Short version].
    Schmitz T; Sentilhes L; Lorthe E; Gallot D; Madar H; Doret-Dion M; Beucher G; Charlier C; Cazanave C; Delorme P; Garabedian C; Azria É; Tessier V; Senat MV; Kayem G
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):998-1003. PubMed ID: 30392986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Classic Mid-Trimester Preterm Premature Rupture of Membranes (PPROM) with Oligo/Anhydramnion between 22 and 26 Weeks of Gestation by Means of Continuous Amnioinfusion: Protocol of a Randomized Multicentric Prospective Controlled TRIAL and Review of the Literature.
    Tchirikov M; Haiduk C; Tchirikov M; Riemer M; Bergner M; Li W; Henschen S; Entezami M; Wienke A; Seliger G
    Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in noninvasively obtained amniotic fluid as predictors of fetal inflammatory response syndrome.
    Kunze M; Klar M; Morfeld CA; Thorns B; Schild RL; Markfeld-Erol F; Rasenack R; Proempeler H; Hentschel R; Schaefer WR
    Am J Obstet Gynecol; 2016 Jul; 215(1):96.e1-8. PubMed ID: 26829512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous amnioinfusion for treatment of mid-trimester preterm premature rupture of membranes with oligoamnios.
    Ono T; Tsumura K; Kawasaki I; Ikeda M; Hideshima M; Tsuda S; So K; Kawaguchi A; Nomiyama M; Yokoyama M
    J Obstet Gynaecol Res; 2020 Jan; 46(1):79-86. PubMed ID: 31650672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preterm premature rupture of the membranes: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).
    Schmitz T; Sentilhes L; Lorthe E; Gallot D; Madar H; Doret-Dion M; Beucher G; Charlier C; Cazanave C; Delorme P; Garabédian C; Azria E; Tessier V; Sénat MV; Kayem G
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():1-6. PubMed ID: 30870741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic fluid volume at presentation with early preterm prelabor rupture of membranes and association with severe neonatal respiratory morbidity.
    Weiner E; Barrett J; Zaltz A; Ram M; Aviram A; Kibel M; Lipworth H; Asztalos E; Melamed N
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):767-773. PubMed ID: 30834608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of preterm premature rupture of membranes (except for antibiotherapy): CNGOF preterm premature rupture of membranes guidelines].
    Madar H
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):1029-1042. PubMed ID: 30389540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and maternal outcomes following preterm premature rupture of membrane in the second trimester of gestation.
    Gafner M; Borovich A; Gimpel A; Peled Y; Meshulam M; Krissi H
    Arch Gynecol Obstet; 2020 May; 301(5):1207-1212. PubMed ID: 32274636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies.
    Simhan HN; Canavan TP
    BJOG; 2005 Mar; 112 Suppl 1():32-7. PubMed ID: 15715592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amnioinfusion in preterm premature rupture of membranes (AMIPROM): a randomised controlled trial of amnioinfusion versus expectant management in very early preterm premature rupture of membranes--a pilot study.
    Roberts D; Vause S; Martin W; Green P; Walkinshaw S; Bricker L; Beardsmore C; Shaw BN; McKay A; Skotny G; Williamson P; Alfirevic Z
    Health Technol Assess; 2014 Apr; 18(21):1-135. PubMed ID: 24713309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of latency period in PPROM cases managed expectantly.
    Baser E; Aydogan Kirmizi D; Ulubas Isik D; Ozdemirci S; Onat T; Serdar Yalvac E; Demirel N; Moraloglu Tekin O
    J Matern Fetal Neonatal Med; 2020 Jul; 33(13):2274-2283. PubMed ID: 32089027
    [No Abstract]   [Full Text] [Related]  

  • 16. [Feasibility study of expectant management of different degrees of vaginal fluid in pregnant women with premature rupture of membranes in the second trimester].
    Gao YM; Wu SH; Shang HX; Yang YL; Zhou BH; Yang X
    Zhonghua Fu Chan Ke Za Zhi; 2024 Feb; 59(2):121-129. PubMed ID: 38389231
    [No Abstract]   [Full Text] [Related]  

  • 17. Test amnioinfusion to determine suitability for serial therapeutic amnioinfusion in midtrimester premature rupture of membranes.
    Tan LK; Kumar S; Jolly M; Gleeson C; Johnson P; Fisk NM
    Fetal Diagn Ther; 2003; 18(3):183-9. PubMed ID: 12711874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized treatment of preterm premature rupture of membranes to prolong the latency period, reduce the rate of preterm birth, and improve neonatal outcomes.
    Ronzoni S; Cobo T; D'Souza R; Asztalos E; O'Rinn SE; Cao X; Herranz A; Melamed N; Ferrero S; Barrett J; Aldecoa V; Palacio M
    Am J Obstet Gynecol; 2022 Aug; 227(2):296.e1-296.e18. PubMed ID: 35257664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of meconium-stained amniotic fluid on perinatal outcome in pregnancies complicated by preterm premature rupture of membranes.
    Wertheimer A; Shemer A; Hadar E; Berezowsky A; Wiznitzer A; Krispin E
    Arch Gynecol Obstet; 2020 May; 301(5):1181-1187. PubMed ID: 32303889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Preterm Premature Rupture of Membranes with Oligo-/Anhydramnion Colonized by Multiresistant Bacteria with Continuous Amnioinfusion and Antibiotic Administrations through a Subcutaneously Implanted Intrauterine Port System: A Case Report.
    Tchirikov M; Zhumadilov Z; Winarno AS; Haase R; Buchmann J
    Fetal Diagn Ther; 2017; 42(1):71-76. PubMed ID: 26447923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.